Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Drug dealing among the youth.
Drug dealing among the youth. - Credit: photographee.eu / DepositPhotos - License: DepositPhotos
Politics
1-1-2
designer drug
ban
opium act
Thursday, 27 May 2021 - 12:42

Share this article:

Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window

The Netherlands restricts designer drug 3-MMC

State Secretary of Health Paul Blokhuis has decided to severely restrict legal access to designer drug 3-MMC by placing it on the List II of prohibited substances under the Opium Act. The decision was taken out of concern that the drug, which is linked to numerous health risks, was becoming more popular among young people in the Netherlands.

”The legal status gives this drug a false, innocent image, we must get rid of that as soon as possible. It is dangerous stuff which we have to protect ourselves from by warning our youth against it,” Blokhuis stated.

The ban on 3-MMC is expected to take effect in the autumn of 2021. The drug is already illegal in most countries. Restricting access is meant to alert the population that the use of 3-MMC can lead to serious health risks. Cardiac arrhythmias, elevated blood pressure or high body temperature are among health concerns connected to the use of the drug.

According to the coordination point for the assessment and monitoring of new drugs (CAM), the number of health emergencies after use of 3-MMC has been on the rise. Moreover, due to its current legal status, the drug was easily and widely available.

“3-MMC is becoming increasingly popular, especially among young people. We are receiving worrying signals about this drug from various parts of the country. I am pleased that the CAM has reached an assessment in such a short time, so that we can now take action,” Blokhuis stated.

The CAM also recommends raising awareness among users of 3-MMC of the negative health effects associated with its use. That is why, in addition to the ban, the monitoring body will also make efforts to provide information and improve prevention.

More like this

Image
Pills
Growing concerns about self-medication through online shops spark Trimbos study
Image
A small bag with several grams of the designer drug, 3-Methylmethcathinone, better known as 3-MMC, alongside a euro note used to snort a line off a mirror. October 2021
At least 8 illegal designer drug sites back online via a foreign domain
Image
Pharmaceuticals seized from Funcaps in August 2025
Evidence proves at least 18 deaths linked to designer drug site Funcaps, prosecutor says
Image
A small bag with several grams of the designer drug, 3-Methylmethcathinone, better known as 3-MMC, alongside a euro note used to snort a line off a mirror. October 2021
Dutch companies imported €2 billion worth of dangerous designer drugs from India
Make NL Times your top Google source

Follow us:

Latest stories

  • Viewing events planned across Netherlands for rare near-total solar eclipse on August 12
  • Haarlemmerbuurt residents, businesses fed up with harassment by addicted homeless people
  • Police evacuate homes overnight after explosive found at Amsterdam toy shop; 2 arrested
  • Amsterdam mayor plans extra Pride security measures after 1 killed in Berlin
  • Dutch man missing on Lake Como after diving to save son; Small kids left on boat adrift

Top stories

  • Amsterdam mayor plans extra Pride security measures after 1 killed in Berlin
  • Dutch man missing on Lake Como after diving to save son; Small kids left on boat adrift
  • Mayor, Queen open WorldPride; Mayor says: Adapt to queers or you don’t belong here
  • 9 hospitalized amid heat, 4 arrested on firearm charges at Rotterdam Summer Carnival
  • British man sentenced to 5 years for stabbing tourist, another victim in Amsterdam

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content